Process for the Preparation of 2-(4-alkyl-1-piperazinyl)-benzaldehyde and benzylidenyl Compounds

Details for Australian Patent Application No. 2002300770 (hide)

Owner Pfizer Products Inc.

Inventors Sinay Jr., Terry Gene; Walinsky, Stanley Walter; Rainville, Joseph Philip

Agent Spruson & Ferguson

Pub. Number AU-B-2002300770

Priority 60316010 30.08.01 US

Filing date 28 August 2002

Wipo publication date 12 June 2003

Acceptance publication date 7 June 2007

International Classifications

C07D 295/112 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 279/12 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

Event Publications

12 June 2003 Application Open to Public Inspection

  Published as AU-B-2002300770

7 June 2007 Application Accepted

  Published as AU-B-2002300770

4 October 2007 Standard Patent Sealed

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300771-Software Patch Generator

2002300769-Single operator stenting system